Geneticure is a personalized medicine company with patented tests that control chronic diseases faster than trial/error, with less cost
Geneticure has raised $1.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in October 2026.
Geneticure's investors include M25, Wireframe Ventures, Mayo Clinic Ventures, Xcellerant Ventures, Fairview Health Services.
Geneticure is headquartered in Minneapolis, United States.
Geneticure is a personalized medicine company with patented tests that control chronic diseases faster than trial/error, with less cost
Geneticure is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Geneticure — Funding & Investors." VCBacked, October 21, 2026, https://www.vcbacked.co/company/geneticure. Accessed November 18, 2026.
VCBacked. (2026). Geneticure — Funding & Investors. Retrieved November 18, 2026, from https://www.vcbacked.co/company/geneticure
{{cite web |title=Geneticure — Funding & Investors |url=https://www.vcbacked.co/company/geneticure |website=VCBacked |access-date=November 18, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Geneticure? Request a listing update